MacroGenics
MGNX
#8502
Rank
ยฃ0.16 B
Marketcap
ยฃ2.56
Share price
-3.61%
Change (1 day)
165.81%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.10 Billion

According to MacroGenics's latest financial reports the company has ยฃ0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.16 B-10.91%
2023-12-31ยฃ0.18 B41.39%
2022-12-31ยฃ0.12 B-29.31%
2021-12-31ยฃ0.18 B-9.73%
2020-12-31ยฃ0.19 B21.52%
2019-12-31ยฃ0.16 B-10.31%
2018-12-31ยฃ0.18 B-18.74%
2017-12-31ยฃ0.22 B0.57%
2016-12-31ยฃ0.22 B-1.88%
2015-12-31ยฃ0.22 B126.03%
2014-12-31ยฃ0.10 B43.34%
2013-12-31ยฃ70.61 M139.06%
2012-12-31ยฃ29.53 M-16.85%
2011-12-31ยฃ35.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
ยฃ10.03 B 9,187.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ5.36 B 4,864.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.74 B 6,135.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.09 B 6,466.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ10.75 B 9,848.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.88 B 7,190.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.40 B 274.14%๐Ÿ‡บ๐Ÿ‡ธ USA